Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18] FDG-PET in patients with newly diagnosed metastatic renal cell carcinoma

S. Verhoeff; S. C. van Es; E. Boon; E. van Helden; L. Angus; S. G. Elias; S. F. Oosting; E. H. Aarntzen; A. H. Brouwers; T. C. Kwee; S. Heskamp; O. S. Hoekstra; H. Verheul; G. J. C. Zwezerijnen; C. Menke-van der Houven van Oordt; A. A. M. van der Veldt; E. G. E. de Vries; O. C. Boerman; W. T. A. van der Graaf; W. J. G. Oyen; C. M. L. van Herpen

Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18] FDG-PET in patients with newly diagnosed metastatic renal cell carcinoma

S. Verhoeff, S. C. van Es, E. Boon, E. van Helden, L. Angus, S. G. Elias, S. F. Oosting, E. H. Aarntzen, A. H. Brouwers, T. C. Kwee, S. Heskamp, O. S. Hoekstra, H. Verheul, G. J. C. Zwezerijnen, C. Menke-van der Houven van Oordt, A. A. M. van der Veldt, E. G. E. de Vries, O. C. Boerman, W. T. A. van der Graaf, W. J. G. OyenC. M. L. van Herpen

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	S67-S67
Journal	European journal of nuclear medicine and molecular imaging
Volume	46
Issue number	SUPPL 1
Publication status	Published - Oct 2019

Cite this

Verhoeff, S., van Es, S. C., Boon, E., van Helden, E., Angus, L., Elias, S. G., Oosting, S. F., Aarntzen, E. H., Brouwers, A. H., Kwee, T. C., Heskamp, S., Hoekstra, O. S., Verheul, H., Zwezerijnen, G. J. C., van Oordt, C. M. D. H., van der Veldt, A. A. M., de Vries, E. G. E., Boerman, O. C., van der Graaf, W. T. A., ... van Herpen, C. M. L. (2019). Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18] FDG-PET in patients with newly diagnosed metastatic renal cell carcinoma. European journal of nuclear medicine and molecular imaging, 46(SUPPL 1), S67-S67.

@article{821efbad7fa143a1b176945711e85593,

title = "Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18] FDG-PET in patients with newly diagnosed metastatic renal cell carcinoma",

author = "S. Verhoeff and {van Es}, {S. C.} and E. Boon and {van Helden}, E. and L. Angus and Elias, {S. G.} and Oosting, {S. F.} and Aarntzen, {E. H.} and Brouwers, {A. H.} and Kwee, {T. C.} and S. Heskamp and Hoekstra, {O. S.} and H. Verheul and Zwezerijnen, {G. J. C.} and {van Oordt}, {C. Menke-van der Houven} and {van der Veldt}, {A. A. M.} and {de Vries}, {E. G. E.} and Boerman, {O. C.} and {van der Graaf}, {W. T. A.} and Oyen, {W. J. G.} and {van Herpen}, {C. M. L.}",

year = "2019",

month = oct,

language = "English",

volume = "46",

pages = "S67--S67",

journal = "European journal of nuclear medicine and molecular imaging",

issn = "1619-7070",

publisher = "Springer Verlag",

number = "SUPPL 1",

}

Verhoeff, S, van Es, SC, Boon, E, van Helden, E, Angus, L, Elias, SG, Oosting, SF, Aarntzen, EH, Brouwers, AH, Kwee, TC, Heskamp, S, Hoekstra, OS, Verheul, H, Zwezerijnen, GJC , van Oordt, CMDH, van der Veldt, AAM, de Vries, EGE, Boerman, OC, van der Graaf, WTA, Oyen, WJG & van Herpen, CML 2019, 'Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18] FDG-PET in patients with newly diagnosed metastatic renal cell carcinoma', European journal of nuclear medicine and molecular imaging, vol. 46, no. SUPPL 1, pp. S67-S67.

TY - JOUR

T1 - Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18] FDG-PET in patients with newly diagnosed metastatic renal cell carcinoma

AU - Verhoeff, S.

AU - van Es, S. C.

AU - Boon, E.

AU - van Helden, E.

AU - Angus, L.

AU - Elias, S. G.

AU - Oosting, S. F.

AU - Aarntzen, E. H.

AU - Brouwers, A. H.

AU - Kwee, T. C.

AU - Heskamp, S.

AU - Hoekstra, O. S.

AU - Verheul, H.

AU - Zwezerijnen, G. J. C.

AU - van Oordt, C. Menke-van der Houven

AU - van der Veldt, A. A. M.

AU - de Vries, E. G. E.

AU - Boerman, O. C.

AU - van der Graaf, W. T. A.

AU - Oyen, W. J. G.

AU - van Herpen, C. M. L.

PY - 2019/10

Y1 - 2019/10

M3 - Meeting Abstract

SN - 1619-7070

VL - 46

SP - S67-S67

JO - European journal of nuclear medicine and molecular imaging

JF - European journal of nuclear medicine and molecular imaging

IS - SUPPL 1

ER -